therapeutics Asset indications discovery non-clinical clinical
Small molecules CR-C003 Autoimmune disease* on on  
CR-C00X B-cell lymphoma on on  
Gene therapy (Adeno-associated virus) CR-G001 HCC on on  
Therapeutic proteins CR-T1~T4 Autoimmune disease* on on  

* Our autoimmune disease treatment candidates are being developed as indications for psoriasis, psoriatic arthritis, rheumatoid arthritis and/or inflammatory bowel disease. Indications will be extended to ankylosing spondylitis and graft-versus-host disease on medical and experimental basis.